We have recently demonstrated that peripheral blood mononuclear cells (PBMCs) of patients with relapsing-remitting MS (RR-MS) secrete higher levels of EGF compared to matched healthy controls, indicating a potential effect of immune cells on the insufficient neuronal and oligodendroglial regeneration in MS. This evidence concerns the gene EGF and myeloid sarcoma.